Provide CRO services for innovative drugs
• Technical advantages: versatile for different drug release profiles, low costs for excipients and equipment, ease for manufacturing, consistent product quality, and improved market competency of products.
• Multi-polymer Systems can provide extended release profiles matching that of the Osmotic Pump technology.
• Several ANDAs using the Multi-polymer System that are bioequivalent to the original osmotic pump formulations have been approved and successfully commercialized.